Skip to main content
Log in

CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Fliegert F, Kurth B, Gohler K (2005) The effects of tramadol on static and dynamic pupillometry in healthy subjects—the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Eur J Clin Pharmacol (published online 20 May, DOI 10.1007/s00228-005-0920-y)

  2. Slanař O, Perlík F (2004) CYP2D6 polymorphism and miotic effect of tramadol in healthy volunteers. Drug Metab Rev 36[Suppl 1]:114

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ondřej Slanař.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slanař, O., Nobilis, M., Květina, J. et al. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response. Eur J Clin Pharmacol 62, 75–76 (2006). https://doi.org/10.1007/s00228-005-0039-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0039-1

Keywords

Navigation